Pascal Soriot about statement that AstraZeneca will buy Alexion for $39 bln

Pascal Soriot: It is a tremendous opportunity for us to accelerate our development in immunology, getting into a new segment of disease, a new segment of physicians, and patients we haven’t been able to cover so far.

It is a tremendous opportunity for us to accelerate our development in immunology, getting into a new segment of disease, a new segment of physicians, and patients we haven’t been able to cover so far.

Read more:

More about AstraZeneca:

- Anthony Fauci
- AstraZeneca
- Coronavirus
- Vaccine
- United States
- World
- © Shutterstock
- Anthony Fauci
- AstraZeneca
- NIAID
- Effectiveness
- Vaccine
- Coronavirus
- United States
- World
- © Shutterstock
- Tedros Adhanom
- AstraZeneca
- Coronavirus
- Vaccine
- World Health Organization
- Blood Clots
- World
- © Shutterstock
- Anthony Fauci
- Coronavirus
- Vaccine
- AstraZeneca
- United States
- World
- © Shutterstock

Latest News

- Hans-Dieter Flick
- Bayern Munich
- PSG
- Champions League
- Defeat
- Semifinals
- Football
- Sports
- © Shutterstock
- Anne Schuchat
- Johnson & Johnson
- Blood Clot Concerns
- Vaccine
- Ban
- United States
- World
- © Shutterstock
- Conor McGregor
- Dustin Poirier
- UFC
- Donation
- Cancelled
- MMA
- Sports
- © Shutterstock
- Christina Aguilera
- Skinny
- Music
- Body Insecurity
- Life
- © Shutterstock